Endocrinology News

DENVER — Women with type 2 diabetes prescribed any GLP-1 receptor agonist were less likely to develop any new-onset uterine fibroids over 5 years compared with those who used metformin or insulin, researchers reported.

The rate of metabolic bariatric surgery decreased from 2022 to 2023, whereas the use of GLP-1 receptor agonists as anti-obesity medications grew over twofold, a research letter showed.

BOSTON — Addiction to ultraprocessed food may be diagnosed similarly to other substance use disorders, and reducing stigma and tailored treatment are both important to improving cardiometabolic health, a speaker reported.

Data from a phase 3 trial designed to compare pralsetinib with standard therapy for certain patients with advanced lung cancer revealed a risk for severe — and potentially fatal — infections with the drug, according to its manufacturer.

DENVER — In this Healio video exclusive, Jodi Flaws, PhD, discusses how exposure to a group of chemicals commonly found in plastics, cosmetics and personal care items may be tied to reproductive aging symptoms in women.

Clinical and genetic risk factors can help identify individuals at risk for immune checkpoint inhibitor-induced diabetes, according to results of a cohort study.

Expanding access to weight loss medications could save tens of thousands of lives annually, according to an analysis published in PNAS.

In patients with type 2 diabetes, semaglutide was associated with a significantly lower risk for an Alzheimer’s disease diagnosis within 3 years compared with other diabetes medications, according to a study published in Alzheimer’s & Dementia.

BOSTON — In this Healio video exclusive, Virend K. Somers, MD, PhD, discusses his presentation at the Cardiometabolic Health Congress, “Sleep Disorders and Cardiometabolic Health.”

Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.